Oncology
Piro Lito, M.D., PH.D.
Director of Basic and Translational Research, Enid A Haupt Chair in Therapeutic Research, Professor, Memorial Sloan Kettering Cancer Center
Dr. Piro Lito is a thoracic medical oncologist at Memorial Sloan Kettering Cancer Center (MSKCC) in New York, NY, specializing in lung cancer treatment and research. He focuses on patients with advanced non-small cell lung cancer (NSCLC), particularly those with KRAS mutations, which drive approximately 25% of lung cancers. His clinical practice emphasizes targeted therapies, including inhibitors like sotorasib (KRAS G12C inhibitor), the first FDA-approved KRAS-directed therapy, which he co-led
17+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
- Internal Medicine (American Board of Internal Medicine)
Education & Training
- Michigan State University College of Human Medicine — MD, PhD, Class of 2008
- Beth Israel Deaconess Medical Center — Residency, Internal Medicine, 2008 - 2010
- Memorial Sloan Kettering Cancer Center — Fellowship, Hematology and Medical Oncology, 2010 - 2014
Peer Recognition
- Falling Walls Foundation — Life Sciences Breakthroughs of the Year
2022
- Foundation for the National Institutes of Health — Trailblazer Prize for Clinician Scientists
- Pershing Square Sohn Cancer Research Alliance — Pershing Square Sohn Prize
2022
- Pew Charitable Trusts — Pew Stewart Scholar for Cancer Research
2019
- The American Society for Clinical Investigation — Seldin Smith Award for Pioneering Research
2022
Recognition & Leadership
Awards & Honors
- ASCI Seldin Smith Award (2022)
- 2022 Pershing Square Sohn Prize for Young Investigators
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Memorial Sloan Kettering Cancer Center
Languages
English
Experience
17+ years in practice